23 results
·
24ms
·
Sources: EU EUDAMED, US FDA
MultiScan G-Arm System
FDA 510(k)
FDA Class 2
·Radiology
CoRoent
FDA UDI
Nuvasive, Inc.·00887517566300·CoRoent Ant TLIF PEEK, 15x11x28mm 0°
AGXO
FDA UDI
Oticon A/S·05707131288158·H330V2, DESIGNRITE 10 WL SOR AGXO
ProLift
FDA UDI
Life Spine, Inc.·00190837117511·
Crosslink Bonding Adhesives
FDA UDI
TP ORTHODONTICS INC·00192029000113·In Preloaded Syringe Natural Color Paste 24 g (...
Pro Lift Instruments
FDA UDI
Life Spine, Inc.·00190837031138·
Ophthalmic Speculum
FDA UDI
KATENA PRODUCTS, INC.·00841668100257·CHU ASPIRATING SPECULUM SOLID
HNM SPORTS MEDICINE
FDA UDI
HNM STAINLESS, LLC.·00812171029908·ETHOS PRO LABRAL ANCHOR, PEEK, 3.3mm x 6mm, (1)...
Endo-Model Knee System - Instruments
FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575292998·Knee femur prosthesis trial - General Instrument
Endo-Model Knee System - Instruments
FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575292769·Knee femur prosthesis trial - General Instrument
Endo-Model Knee System - Instruments
FDA UDI
WALDEMAR LINK GmbH & Co. KG·04026575292509·Knee femur prosthesis trial - General Instrument
MEDCOMP SPLIT CATH II
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
MIDWESTERN REPROCESSING CENTER REPROCESSED PULSE OXIMETER PROBE
FDA 510(k)
FDA Class 2
·Cardiovascular
HNM SPORTS MEDICINE
FDA UDI
HNM STAINLESS, LLC.·00842962103708·ETHOS PRO LABRAL ANCHOR, PEEK, 3.3mm x 6mm, (1)...
ACCU-CHEK ® SPIRIT COMBO
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code LZG·October 8, 2014
REACH ACCESS DAILY FLOSSER
FDA Adverse Event
Malfunction
·JOHNSON & JOHNSON CONSUMER PRODUCTS·Product code JES·June 7, 2013
ASR UNI FEMORAL IMPL SIZE 43
FDA Adverse Event
Injury
·DEPUY INTERNATIONAL, LTD.·Product code KWA·June 30, 2011
LIFE SCOPE G9
FDA Adverse Event
Malfunction
·NIHON KOHDEN CORPORATION·Product code MHX·June 13, 2024
LIFE SCOPE G9
FDA Adverse Event
Malfunction
·NIHON KOHDEN CORPORATION·Product code MHX·October 27, 2023
SL & SLi Series (Mod 15/18/20/25) Linear Accelerator Used for radiation therapy treatments of malignant neoplastics diseases.
FDA Enforcement
Class II
·Terminated·Elekta, Inc.·March 26, 2014